Chondrosarcoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Chondrosarcoma}} | {{Chondrosarcoma}} | ||
{{CMG}} | {{CMG}};{{AE}} {{PSK}} | ||
==Overview== | ==Overview== | ||
Revision as of 19:12, 2 September 2015
|
Chondrosarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Chondrosarcoma medical therapy On the Web |
|
American Roentgen Ray Society Images of Chondrosarcoma medical therapy |
|
Risk calculators and risk factors for Chondrosarcoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]
Overview
Chemotherapy and radiotherapy are indicated for chondrosarcoma as adjuvant therapy. Proton therapy is a new kind of radiotherapy showing promising results with local tumor control at over 80%.
Medical Therapy
- Chemotherapy or traditional radiotherapy are not very effective for most chondrosarcomas.
- Proton therapy is showing promise with local tumor control at over 80%.[1]
- Proton therapy Radiation can be useful in rare locations such as skull base, spine, rib cage, or larynx to make surgery more effective.
- Recent studies have shown that induction of apoptosis in high-grade chondrosarcoma, both directly and by enhancement of response to chemotherapy and radiation, is a valid therapeutic strategy